Vertical integration for CDMOs in manufacturing ADCs offers an opportunity to reduce costs and create a more resilient supply ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

A Northwestern Medicine study has uncovered a promising new therapeutic approach for a rare genetic brain disorder, according ...

In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

The new company combines Tahoe’s AI-powered target discovery engine with Alloy’s industry-leading ADC development ...

People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Celltrion outlines a blueprint for innovative drug development built on its antibody expertiseThe company highlights its ...

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program.  Shine-On ...

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch ...